Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.063 SEK | -8.29% | +5.09% | -59.60% |
04-15 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
04-04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.60% | 67.6M | |
+3.91% | 109B | |
+10.87% | 105B | |
-0.20% | 22.25B | |
-13.14% | 22.09B | |
-7.75% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- ONCO Stock
- News Oncopeptides AB
- Oncopeptides Secures EU Committee Backing for Expanded Indication of Multiple Myeloma Therapy; Shares Surge